Leerink Swann Maintains an 'Outperform' on InterMune (ITMN); Downside Scenario Manageable; Valuation Attractive
Tweet
Share
E-mailGet Alerts ITMN Hot Sheet
Price: $73.89 --0%
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Leerink Swann maintains an 'Outperform' on InterMune Inc. (NASDAQ: ITMN) price target of $54.00.
Leerink analyst says, "We hosted an investor call yesterday with a MEDACorp German reimbursement specialist to discuss the impact of the German Institute for Quality and Efficiency in Health Care (IQWiG) assessment on Esbriet. We believe the downside scenario of the German AMNOG review (price review after first launch anniversary) would be taking the average EU5 pricing, or pan-European pricing. Considering the sell-off in the shares yesterday and the significant concern over the last several months about European pricing and the launch that has taken the shares to the level prior to European approval, we believe this scenario is relatively benign and the valuation is attractive at current levels."
For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.
Shares of InterMune Inc. closed at $12.74 yesterday.
Leerink analyst says, "We hosted an investor call yesterday with a MEDACorp German reimbursement specialist to discuss the impact of the German Institute for Quality and Efficiency in Health Care (IQWiG) assessment on Esbriet. We believe the downside scenario of the German AMNOG review (price review after first launch anniversary) would be taking the average EU5 pricing, or pan-European pricing. Considering the sell-off in the shares yesterday and the significant concern over the last several months about European pricing and the launch that has taken the shares to the level prior to European approval, we believe this scenario is relatively benign and the valuation is attractive at current levels."
For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.
Shares of InterMune Inc. closed at $12.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
- BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
- B.Riley Downgrades Lantheus Holdings (LNTH) to Neutral
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
